BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 2819041)

  • 1. Inhibition of electron transfer from adrenodoxin to cytochrome P-450scc by chemical modification with pyridoxal 5'-phosphate: identification of adrenodoxin-binding site of cytochrome P-450scc.
    Tsubaki M; Iwamoto Y; Hiwatashi A; Ichikawa Y
    Biochemistry; 1989 Aug; 28(17):6899-907. PubMed ID: 2819041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational change of the heme moiety of the ferrous cytochrome P-450scc-phenyl isocyanide complex upon binding of reduced adrenodoxin.
    Tsubaki M; Hiwatashi A; Ichikawa Y
    Biochemistry; 1989 Dec; 28(25):9777-84. PubMed ID: 2611261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chemical modification of cholesterol-hydroxylating cytochrome P-450 from adrenal cortex mitochondria with diethylpyrocarbonate].
    Pikuleva IA; Usanov SA; Chashchin VL
    Biokhimiia; 1990 Apr; 55(4):665-73. PubMed ID: 2378912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of phospholipid and detergent on the substrate specificity of adrenal cytochrome P-450scc. Substrate binding and kinetics of cholesterol side chain oxidation.
    Greenfield NJ; Gerolimatos B; Szwergold BS; Wolfson AJ; Prasad VV; Lieberman S
    J Biol Chem; 1981 May; 256(9):4407-17. PubMed ID: 6260797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-linking studies of the cholesterol hydroxylation system from bovine adrenocortical mitochondria.
    Turko IV; Adamovich TB; Kirillova NM; Usanov SA; Chashchin VL
    Biochim Biophys Acta; 1989 Jun; 996(1-2):37-42. PubMed ID: 2736257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-linking studies of adrenocortical cytochrome P-450scc. Evidence for a covalent complex with adrenodoxin and localization of the adrenodoxin-binding domain.
    Chashchin VL; Turko IV; Akhrem AA; Usanov SA
    Biochim Biophys Acta; 1985 Apr; 828(3):313-24. PubMed ID: 3838683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electron transfer to cytochrome P-450scc limits cholesterol-side-chain-cleavage activity in the human placenta.
    Tuckey RC; Woods ST; Tajbakhsh M
    Eur J Biochem; 1997 Mar; 244(3):835-9. PubMed ID: 9108254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active complex between adrenodoxin reductase and adrenodoxin in the cytochrome P-450scc reduction reaction.
    Hara T; Kimura T
    J Biochem; 1989 Apr; 105(4):601-5. PubMed ID: 2503499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Participation of the membrane in the side chain cleavage of cholesterol. Reconstitution of cytochrome P-450scc into phospholipid vesicles.
    Seybert DW; Lancaster JR; Lambeth JD; Kamin H
    J Biol Chem; 1979 Dec; 254(23):12088-98. PubMed ID: 500697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electron paramagnetic resonance study of ferrous cytochrome P-450scc-nitric oxide complexes: effects of 20(R),22(R)-dihydroxycholesterol and reduced adrenodoxin.
    Tsubaki M; Hiwatashi A; Ichikawa Y; Fujimoto Y; Ikekawa N; Hori H
    Biochemistry; 1988 Jun; 27(13):4856-62. PubMed ID: 2844242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrimination between conformational states of mitochondrial cytochrome P-450scc by selective modification with pyridoxal 5-phosphate.
    Lapko AG; Ruckpaul K
    Biochemistry (Mosc); 1998 May; 63(5):568-72. PubMed ID: 9632894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of chemical modification of tyrosine residues of cholesterol-hydroxylating cytochrome P-450 on the interaction with high-spin effectors].
    Chashchin VL; Pikuleva IA; Akhrem AA; Usanov SA
    Biokhimiia; 1985 Jan; 50(1):128-38. PubMed ID: 3978151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The formation of binary and ternary complexes of cytochrome P-450scc with adrenodoxin and adrenodoxin reductase.adrenodoxin complex. The implication in ACTH function.
    Kido T; Kimura T
    J Biol Chem; 1979 Dec; 254(23):11806-15. PubMed ID: 227881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescein isothiocyanate specifically modifies lysine 338 of cytochrome P-450scc and inhibits adrenodoxin binding.
    Tuls J; Geren L; Millett F
    J Biol Chem; 1989 Oct; 264(28):16421-5. PubMed ID: 2506177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunochemical characteristics of cholesterol-hydroxylating cytochrome P-450 from adrenal cortex mitochondria].
    Usanov SA; Turko IV; Akhrem AA; Chashchin VL
    Biokhimiia; 1984 Nov; 49(11):1810-8. PubMed ID: 6441602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the immunochemical properties of human placental and bovine adrenal cholesterol side-chain cleavage enzyme complex.
    Usanov SA; Honkakoski P; Lang MA; Pasanen M; Pelkonen O; Raunio H
    Biochim Biophys Acta; 1989 Oct; 998(2):189-95. PubMed ID: 2790061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A shunted system of electron transport from NAD(P)H to cholesterol-hydroxylating cytochrome P-450 in adrenal cortex mitochondria].
    Usanov SA; Chernogolov AA; Chashchin VL; Akhrem AA
    Biokhimiia; 1985 Oct; 50(10):1702-11. PubMed ID: 4074778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The domain structure of the cholesterol side-chain cleavage cytochrome P-450 from bovine adrenocortical mitochondria.
    Chashchin VL; Vasilevsky VI; Shkumatov VM; Akhrem AA
    Biochim Biophys Acta; 1984 May; 787(1):27-38. PubMed ID: 6722173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative structural and immunochemical characterization of recombinant and natural cytochrome p450scc (CYPXIAI).
    Lepesheva GI; Usanov SA
    Biochemistry (Mosc); 1998 Feb; 63(2):224-34. PubMed ID: 9526119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroidogenic electron transport in adrenal cortex mitochondria.
    Lambeth JD; Seybert DW; Lancaster JR; Salerno JC; Kamin H
    Mol Cell Biochem; 1982 May; 45(1):13-31. PubMed ID: 7050653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.